Neurotech Pharmaceuticals

Neurotech Pharmaceuticals, Inc. specializes in developing innovative therapies for chronic eye diseases using its proprietary Encapsulated Cell Therapy (ECT) platform. The company generates revenue through the research, development, and commercialization of its unique biopharmaceutical products. Founded in 2000, Neurotech has made significant strides in ophthalmology, particularly in treating macular telangiectasia and other retinal disorders. Their groundbreaking work has positioned them as a leader in the biotech industry, with a strong focus on improving patient outcomes through cutting-edge technology.

Recent Posts by Neurotech Pharmaceuticals

1-20 of 40